Nimish Gera

Title: The Innovative Contributions of Nimish Gera

Introduction

Nimish Gera is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates and engineered polypeptides. With a total of 3 patents to his name, Gera's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Among his latest patents is the development of anti-cMet antibody-drug conjugates and their uses. This patent provides innovative antibodies and outlines their applications in treatment. Another significant patent involves polypeptides that bind to complement component C5 or serum albumin. This disclosure details engineered polypeptides that specifically target human complement component C5 and/or serum albumin. It also includes fusion proteins that may be multivalent and multi-specific, along with nucleic acid molecules encoding these engineered polypeptides or fusion proteins. Furthermore, the patent describes pharmaceutical compositions that incorporate these engineered polypeptides or fusion proteins, along with methods for their production and therapeutic use.

Career Highlights

Nimish Gera has worked with prominent companies in the biotechnology sector, including Alexion Pharmaceuticals, Inc. and Mythic Therapeutics, Inc. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Throughout his career, Gera has collaborated with talented individuals such as Bridget Puffer and Julian Chandler. These collaborations have likely enriched his research and development efforts.

Conclusion

Nimish Gera's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments.